|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$73,772.86 |
2.22% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$70,966.27 |
2.14% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$71,018.78 |
2.14% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$70,591.74 |
2.13% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$70,716.75 |
2.13% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$70,637.00 |
2.13% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,443.89 |
2.12% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$70,031.86 |
2.11% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$70,224.00 |
2.11% |
| Waters Corporation |
WAT |
941848103 |
147 |
$70,101.36 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$69,662.12 |
2.10% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$69,778.11 |
2.10% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$69,639.82 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$69,637.27 |
2.10% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$69,866.16 |
2.10% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$69,547.26 |
2.09% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,403.51 |
2.09% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$69,045.82 |
2.08% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$69,208.02 |
2.08% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$68,821.76 |
2.07% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$68,926.78 |
2.07% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$68,611.95 |
2.07% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,727.08 |
2.07% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$68,282.06 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$68,525.94 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$68,302.55 |
2.06% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$68,055.00 |
2.05% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,114.37 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
298 |
$68,176.44 |
2.05% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$67,915.68 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$67,781.69 |
2.04% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$67,396.00 |
2.03% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$67,512.42 |
2.03% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$67,589.93 |
2.03% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$67,071.18 |
2.02% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$66,883.42 |
2.01% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$66,860.46 |
2.01% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$66,583.35 |
2.00% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,226.73 |
1.99% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$65,894.88 |
1.98% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$65,887.00 |
1.98% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$65,715.91 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,079.28 |
1.93% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$63,662.00 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$63,517.71 |
1.91% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$59,751.20 |
1.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$57,749.84 |
1.74% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,932.63 |
1.68% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,545.99 |
1.34% |
| US Dollar |
$USD |
|
24,433 |
$24,433.37 |
0.74% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|